Paradigm Biopharmaceuticals |
Market Cap (30-Oct) $153,476,176 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (26-Oct) 593,492 (0.09%) (455th) |
|
52w High $0.435 |
52w Low $0.135 |
P/E 8.12 |
EPS -0.15 |
[ARTICLE] Chinese walls still standing at Bell Potter
A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 23 August 2022 at 4:34pm.
The Chinese walls at brokerage Bell Potter may not be so thick as to be seen from space, but they do seem rather impenetrable. It’s already known Bell Potter loves speculative ASX-listed osteoarthritis treatment company Paradigm Biopharmaceuticals,
Read ArticlePAR was $1.28 at the close of trade on 22 August 2022
| Recent Articles about ASX:PAR | |
|---|---|
| 29-Oct | Convening Period for Second Meeting of Creditors Extended to 27 ...
company-announcements.afr.com |
| 24-Oct | Further Obsidian Note Redemption - AFR
company-announcements.afr.com |
| 22-Oct | 2026 Notice of Annual General Meeting - AFR
company-announcements.afr.com |
| 21-Oct | Expiry of PAROB Listed Options – Company in Voluntary ... - AFR
company-announcements.afr.com |
| 21-Oct | Further Obsidian Note Redemption and Phase 3 Data Review Update
company-announcements.afr.com |
| 21-Oct | Appendix 3H - Notification of cessation of securities - AFR
company-announcements.afr.com |
| 21-Oct | 30 September 2026 ASX ANNOUNCEMENT - AFR
company-announcements.afr.com |
| 21-Oct | Market Announcement - AFR
company-announcements.afr.com |
| 16-Oct | PPS Shows Significant Pain Benefit in Rest of World Analysis
company-announcements.afr.com |
| 4-Sep | Paradigm Biopharma Melbourne Investor Lunch Briefing - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.